Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 3/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.41 |
| ▸ | GLA | P06280 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 3/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | NQO2 | P16083 | 2/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.38 |
| ▸ | TOP2A | P11388 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phenazine SCHEMBL9174820 | 1.00 | POLB (0.42) | POLBMAPTKDM4EGLALMNA | |
| SCHEMBL10674809 | 0.86 | ALDH1A1 (0.43) | POLBMAPTKDM4ELMNAHSD17B10 | |
| SCHEMBL31578887 | 0.84 | NQO2 (0.65) | POLBMAPTKDM4ELMNAMEN1 | |
| Phenazine SCHEMBL28658053 | 0.83 | MAPT (0.55) | POLBMAPTKDM4ELMNAMEN1 | |
| Quinoline SCHEMBL28332577 | 0.83 | ALDH1A1 (0.53) | MAPTKDM4ELMNAHSD17B10MEN1 | |
| Phenazine SCHEMBL8936740 | 0.82 | NQO2 (0.61) | POLBMAPTKDM4ELMNAMEN1 | |
| SCHEMBL8585681 | 0.81 | NQO2 (0.46) | POLBMAPTKDM4ELMNAMEN1 | |
| SCHEMBL8585680 | 0.81 | NQO2 (0.48) | POLBMAPTKDM4EGLALMNA | |
| Catechol SCHEMBL23541091 | 0.80 | CA2 (0.42) | POLBMAPTKDM4ELMNAHSD17B10 | |
| Phenazine SCHEMBL2873102 | 0.79 | MAPT (0.50) | POLBMAPTKDM4ELMNAHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 156 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114450585-B | Sensor for evaluating target analytes in liquid beverage samples | 通用生物传感私人有限公司 | 2025-02-14 | — | — | CN | claimed |
| CN-117942073-A | Enzyme mediator functionalized polymers for use with analyte sensors | 美敦力迷你迈德公司 | 2024-04-30 | — | — | CN | claimed |
| CN-116249904-A | Method for determining the amount of NAD metabolite from a sample and methods and uses related thereto | 赫尔辛基大学 | 2023-06-09 | — | — | CN | claimed |
| CN-113652464-B | Method for semi-synthesizing mogroside V through enzyme catalysis | 湖南华诚生物资源股份有限公司 | 2023-01-24 | — | — | CN | claimed |
| EP-3774025-A1 | SYSTEM, METHOD AND INTERFACE FOR PARALLEL PROCESSING OF ANTIMICROBIAL SUSCEPTIBILITY TESTS USING DIFFERENT SAMPLES | Selux Diagnostics, Inc. (US) | 2021-02-17 | — | — | EP | claimed |
| US-20200155125-A1 | ORAL SAMPLING APPARATUS AND USES THEREOF | THE PROCTER & GAMBLE COMPANY | 2020-05-21 | — | — | US | claimed |
| US-20200149086-A1 | METHODS FOR IMPROVED RAPID ANTIMICROBIAL SUSCEPTIBILITY TESTING | SeLux Diagnostics, Inc. | 2020-05-14 | — | — | US | claimed |
| EP-3638127-A1 | ORAL SAMPLING APPARATUS AND USES THEREOF | The Procter and Gamble Company (US) | 2020-04-22 | — | — | EP | claimed |
| EP-3559252-A1 | METHODS FOR IMPROVED RAPID ANTIMICROBIAL SUSCEPTIBILITY TESTING | Selux Diagnostics, Inc. (US) | 2019-10-30 | — | — | EP | claimed |
| WO-2019191328-A1 | SYSTEM, METHOD AND INTERFACE FOR PARALLEL PROCESSING OF ANTIMICROBIAL SUSCEPTIBILITY TESTS USING DIFFERENT SAMPLES | SeLux Diagnostics, Inc. (US) | 2019-10-03 | — | — | WO | claimed |
| US-20160108391-A1 | REAGENT COMPOSITIONS HAVING PYRIDINE-CARBOXYLIC ACID-STABILIZED ENZYMES, AS WELL AS METHODS OF MAKING AND USING THE SAME | ROCHE DIABETES CARE, INC. (US) | 2016-04-21 | — | — | US | claimed |
| EP-2994536-A1 | STABILIZATION OF ENZYMES BY NICOTINIC ACID | Roche Diagnostics GmbH (DE) | 2016-03-16 | — | — | EP | claimed |
| EP-2823052-A1 | COMPATIBLE SOLUTE ECTOINE AS WELL AS DERIVATIVES THEREOF FOR ENZYME STABILIZATION | Roche Diagnostics GmbH (DE) | 2015-01-14 | — | — | EP | claimed |
| US-20140363835-A1 | COMPATIBLE SOLUTE ECTOINE AS WELL AS DERIVATIVES THEREOF FOR ENZYME STABILIZATION | ROCHE DIABETES CARE, INC. | 2014-12-11 | — | — | US | claimed |
| WO-2013131885-A1 | COMPATIBLE SOLUTE ECTOINE AS WELL AS DERIVATIVES THEREOF FOR ENZYME STABILIZATION | ROCHE DIAGNOSTICS GMBH (DE) | 2013-09-12 | — | — | WO | claimed |
| EP-2636750-A1 | Compatible solute ectoine as well as derivatives thereof for enzyme stabilization | Roche Diagniostics GmbH (DE) | 2013-09-11 | — | — | EP | claimed |
| US-7175430-B1 | Support materials and imaging method for intraoral diagnostic purposes | 3M ESPE AG (DE) | 2007-02-13 | — | — | US | claimed |
| US-5196314-A | Colorimetric, tetrazole compunds to reduce interference | BOEHRINGER MANNHEIM GMBH (DE) | 1993-03-23 | — | — | US | claimed |
| EP-0239931-B1 | PROCESS AND REAGENT FOR THE DETERMINATION OF SUBSTRATES OR ENZYME ACTIVITIES | Roche Diagnostics GmbH (DE) | 1992-03-18 | — | — | EP | claimed |
| US-5013647-A | Determination of enzyme substrate or enzyme activity, uric acid, creatinine | BOEHRINGER MANNHEIM GMBH (DE) | 1991-05-07 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200149086-A1 | METHODS FOR IMPROVED RAPID ANTIMICROBIAL SUSCEPTIBILITY TESTING | AMPD3, AMPD1, AMPD2 | POLB 154/4885MAPT 4649/4885KDM4E 4444/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.